NCT06059352 Sleep and Central Auditory Processing Disorder in Autism Spectrum Disorder
| NCT ID | NCT06059352 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Loma Linda University |
| Condition | Central Auditory Processing Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-11-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-11-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed study aims to understand poor sleep as a possible cause to CAPD in children and adolescents with ASD (ASD+) compared to ASD youth without CAPD (ASD-), using both caregiver-report and objective clinician administered measures. Additionally, the study will aim to understand the complex relationship between CAPD, sleep, and other associated phenotypic features of ASD such as executive and psychiatric functioning.
Eligibility Criteria
Inclusion Criteria: * Have diagnosis of Autism Spectrum Disorder confirmed by the Autism Diagnostic Observation Schedule and the Social Communication Questionnaire, Lifetime Version which will be filled by the parent * IQ of 50 or higher on the Abbreviated Battery IQ Score Exclusion Criteria: * No confirmed diagnosis of Autism Spectrum Disorder * History of sleep apnea * History of restless leg syndrome * History of any neurological disorders (e.g., seizures, tumors, etc.) * Significant substance use in the past six months * Inpatient hospitalization in the past three months-period
Contact & Investigator
Aarti Nair, PhD
PRINCIPAL INVESTIGATOR
Loma Linda University
Frequently Asked Questions
Who can join the NCT06059352 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Central Auditory Processing Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06059352 currently recruiting?
Yes, NCT06059352 is actively recruiting participants. Contact the research team at falramadhan@llu.edu for enrollment information.
Where is the NCT06059352 trial being conducted?
This trial is being conducted at Loma Linda, United States.
Who is sponsoring the NCT06059352 clinical trial?
NCT06059352 is sponsored by Loma Linda University. The principal investigator is Aarti Nair, PhD at Loma Linda University. The trial plans to enroll 100 participants.